ColoDefense® Multiplex Blood DNA Methylation Test Kit for Colorectal Cancer
This kit detects the presence of multiple DNA methylation biomarkers in a patient’s blood by highly sensitive fluorescent quantitative PCR technique to determine the patient’s risk for colorectal tumor.
Number of views:
1000

ColoDefense®

This kit detects the presence of multiple DNA methylation biomarkers in a patient’s blood by highly sensitive fluorescent quantitative PCR technique to determine the patient’s risk for colorectal tumor.
Retail price
0.0
Market price
0.0
Number of views:
1000
Product serial number
商标名稱:
Multiplex Blood DNA Methylation Test Kit for Colorectal Cancer
Quantity
-
+
Stock:
DETAILS
Parameters

Product features

  1. It can be used for early screening of colorectal cancer, auxiliary diagnosis, and prognosis of postoperative recurrence.
  2. It achieves high sensitivity and specificity through the combination of bioinformatics-based system thermodynamics guided design and simultaneous detection of multiple methylation biomarkers.
  3. It features non-invasive detection and high public acceptance compared to colonoscopy.
  4. It features an easy and fast procedure with low cost;
  5. It can detect advanced adenomas and early CRCs better than other commercially available blood based test products.

Technical performance indicators

Test results of more than 1,000 clinical samples show the following:

  1. The sensitivities of this kit for the detection of stage I colorectal cancer, stage I-IV colorectal cancer and advanced adenomas are 74%, 88% and 45%, respectively.
  2. Its specificity stands at 93%.

 

 Note: This kit is for research use only, but not for clinical diagnosis.

We could not find any corresponding parameters, please add them to the properties table

CONTACT US

Tel:0512-36680291
        17751718557
E-mail:versabioreport@sina.com
Add:Room 207, Building 1, No.232 Yuanfeng Road, Kunshan City, Jiangsu Province